| Financial Year |
March 31 2023 |
| Monetary Funds |
699,150,804.35 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
123,528,407.80 |
| Accounts Receivable |
2,114,357,872.16 |
| Advances to Suppliers |
377,068,876.21 |
| Other Receivables |
56,958,885.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
863,123,189.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,816,393.00 |
| Other Current Assets |
135,050,425.14 |
| Total Current Assets |
9,722,373,654.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
42,359,528.15 |
| Investment Properties |
34,053,204.29 |
| Fixed Assetes |
1,652,449,972.45 |
| Under-construction Projects |
729,668,387.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
598,877,303.84 |
| R&D expenses |
32,110,555.86 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,489,308.20 |
| Deferred Income Tax Assets |
307,384,891.58 |
| Other Non-Current Assets |
310,067,963.00 |
| Sub-Total of Non-Current Assets |
4,429,465,062.17 |
| Total Assets |
14,151,838,716.82 |
| Short-Term Loans |
2,979,972,574.81 |
| Trading Financial liabilities |
-- |
| Notes Payable |
295,472,620.49 |
| Accounts Payable |
2,838,094,224.72 |
| Accounts Received In Advance |
11,149.85 |
| Employee Compensation Payable |
83,858,535.69 |
| Taxes Payable |
80,722,612.66 |
| Interest Payable |
-- |
| Dividend Payable |
8,782,808.53 |
| Other payables |
154,736,822.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
71,934,495.04 |
| Other Current Liabilities |
387,213,715.93 |
| Sub-Total of Current Liabilities |
7,666,254,316.83 |
| Long-term Loans |
756,098,232.04 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
7,895,783.87 |
| Other Non-Current Liabilities |
52,841,456.63 |
| Sub-Total of Non-Current Liabilities |
974,738,612.15 |
| Total Liabilities |
8,640,992,928.98 |
| Paid-In Capital(Or Share Stock) |
2,369,111,152.00 |
| Capital Surplus |
748,524,245.61 |
| Surplus Reserve |
455,110,782.20 |
| LESS:Treasury Stock |
36,660,497.45 |
| Undistributed Profits |
1,692,751,417.68 |
| Minority Stockholder's Interest |
369,773,583.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,141,072,204.81 |
| Owner's Equity（Stockholder's Equity） |
5,510,845,787.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,151,838,716.82 |
